Portal 2

VENUE MAPPING +*Description+* As AXS, I want a mapping done for venues on Core and in Portal, so that events created on Core can be created in Portal and published to the venue pages on AXS.com +*Rationale+* There are venues within each context on Core as well as in Portal, and in the absence of integration between both platforms, no venue association exists today. This requirement is to create a venue mapping solution that would permit the bidirectional flow of event data between platforms. This

http://www.journalijar.com INTERNATIONAL JOURNAL OF ADVANCED RESEARCH RESEARCH ARTICLE Portal vein thrombosis in patients with liver cirrhosis Insights to risk factors, clinical presentation and outcome Afifi F. Afifi 1 , Usama M. Basha 1 , Fady M. Wadea 1 , Abdelaziz E. Samack 2 , Raghda A. Elsherbini 3 1- GIT and hepatology unit, internal medicine department, faculty of medicine, zagazig university. 2- radiology department, faculty of medicine, zagazig university. 3- clinical pathology department

(12). Non- PVT group At presentation (N=26) After 6 months (N=26) p No % No % Gastropathy Gastropathy grade I 3 11.53 4 15.3 0.6 Gastropathy grade II 4 15.38 3 11.5 Gastropathy grade III 3 11.53 0 0 Esophageal varices OV I 2 7.69 3 11.5 OV II 3 11.53 3 11.5 0.09 OV III 5 19.23 2 7.6 OV IV 4 15.38 1 3.8 ISSN 2320-5407 International Journal of Advanced Research (2015), Volume 3, Issue 12, 1539 – 1548 1545 In our study as regards presence of co- morbid factors namely DM and hypertension, the prevalence

Journal of Advanced Research (2015), Volume 3, Issue 12, 1539 –15481546INR levels were less in PVT group than control group but in patients with early stages of liver cirrhosis, no differences in their levels was found between the 2 groups. Therefore, patients with advanced liver cirrhosis and less prolonged coagulation parameters appear to carry a higher risk of PVT compared with patients with advanced liver cirrhosis and markedly prolonged coagulation parameters. These findings

Published Online: December 2015 Key words: Portal vein, Thrombosis, risk factors, cirrhosis. *Corresponding Author Pawan Kumar Thakur Background and objectives: Portal vein thrombosis (PVT) is an increasingly recognized complication of liver cirrhosis. It is associated with worsening liver function, ascites and the occurrence of gastroesophageal variceal bleeding. The aim of this work was to clarify the risk factors, clinical presentation and complications of portal vein thrombosis in Egyptian patients

Careful follow up and consistent monitoring are essential to ensure proper function of the portosystemic stent. While portal venography is excellent at demonstrating stent patency, Doppler ultrasound allows visualization of blood flow within the stent, portal system and hepatic venous system without the need for radiation and contrast injections. According to Boyer,23 TIPS dysfunction occurs in about 80% of treated patients. He suggests using Doppler ultrasound to assess the stent within 24 hours

characteristics of 15 patients were shown in table 1. 4 patients had one focal lesion (26.7%), 3 patients had 2 focal lesions (20%), 5 patients had 3 focal lesions (33.3%), 3 patients had four focal lesions (20%). 11 patients had portal vein thrombosis (73.3%). The mean of the sum of tumoral size in its longitudinal diameter is 10.5 ± 4.1 cm, mean Child Turcotte Pugh score was 6.33 ± 0.3, MELD score 13.7±1.4, PS < 2. The patients were given the planned medications and followed up after 1 month with AFP level, abdominal

In our study as regards presence of co- morbid factors namely DM and hypertension, the prevalence of DM and hypertension was higher in PVT group than non-PVT group, these results match the findings reported by Martinelli et al. (13) who clarified that hypertension and DM were associated with increased risk of PVT. That finding may be attributed to the association of dyslipidemia with diabetes and increased risk of atherosclerosis, so patients with liver cirrhosis and associated diabetes or hypertension

Portal vein thrombosis in patients with liver cirrhosis: insights to risk factors, clinical presentation and outcome Afifi F. Afifi 1, Osama M. Basha 1 , Fady M. Wadea 1, Abdelaziz E. Samack 2, Raghda Abd-elatif Hafez 3 1- GIT and hepatology unit, Internal Medicine department, Faculty of Medicine, Zagazig University. 2- Radiology department, Faculty of Medicine, Zagazig University. 3- Microbiology&Immunology department, Faculty of Medicine, Zagazig University. EGYPT Manuscript Info Abstract

all › 41 Reads Download Add supplementary resources Recommend Portal vein thrombosis in patients with liver cirrhosis: insights to risk factors, clinical presentation and outcome Article in International Journal of Advanced Research 3(12):1539-1548 · December 2015 1st Afifi F Afifi 2nd Osama Basha 6.99 · Zagazig University + 1 3rd Fady Maher Zagazig University Last Raghda Abd Ellatif Hafez 16.2 · Faculty of medicine/Zagazig University.www.zu.edu.eg Show more authors 3 elements are still missing